NO963350D0 - "3'-substituert nukleosid-derivat - Google Patents

"3'-substituert nukleosid-derivat

Info

Publication number
NO963350D0
NO963350D0 NO963350A NO963350A NO963350D0 NO 963350 D0 NO963350 D0 NO 963350D0 NO 963350 A NO963350 A NO 963350A NO 963350 A NO963350 A NO 963350A NO 963350 D0 NO963350 D0 NO 963350D0
Authority
NO
Norway
Prior art keywords
group
nucleoside derivative
substituted nucleoside
substituted
chem
Prior art date
Application number
NO963350A
Other languages
English (en)
Other versions
NO305702B1 (no
NO963350L (no
Inventor
Akira Matsuda
Takuma Sasaki
Original Assignee
Akira Matsuda
Takuma Sasaki
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Matsuda, Takuma Sasaki, Taiho Pharmaceutical Co Ltd filed Critical Akira Matsuda
Publication of NO963350D0 publication Critical patent/NO963350D0/no
Publication of NO963350L publication Critical patent/NO963350L/no
Publication of NO305702B1 publication Critical patent/NO305702B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO963350A 1994-12-13 1996-08-12 3'-substituert nukleosid-derivat eller et av dets farmas°ytisk akseptable salter, anvendelse derav og medisinsk preparat NO305702B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30891294 1994-12-13
JP20864595 1995-08-16
PCT/JP1995/002554 WO1996018636A1 (fr) 1994-12-13 1995-12-13 Derives de nucleoside substitues en 3'

Publications (3)

Publication Number Publication Date
NO963350D0 true NO963350D0 (no) 1996-08-12
NO963350L NO963350L (no) 1996-10-11
NO305702B1 NO305702B1 (no) 1999-07-12

Family

ID=26516961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963350A NO305702B1 (no) 1994-12-13 1996-08-12 3'-substituert nukleosid-derivat eller et av dets farmas°ytisk akseptable salter, anvendelse derav og medisinsk preparat

Country Status (18)

Country Link
US (2) US5763418A (no)
EP (1) EP0747389B1 (no)
JP (1) JP3142874B2 (no)
KR (1) KR0177372B1 (no)
CN (1) CN1195768C (no)
AT (1) ATE249471T1 (no)
AU (1) AU674639B2 (no)
CA (1) CA2182707C (no)
DE (1) DE69531729T2 (no)
DK (1) DK0747389T3 (no)
ES (1) ES2206522T3 (no)
FI (1) FI118967B (no)
HU (1) HU217772B (no)
NO (1) NO305702B1 (no)
NZ (1) NZ297100A (no)
PT (1) PT747389E (no)
RU (1) RU2130029C1 (no)
WO (1) WO1996018636A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2130029C1 (ru) * 1994-12-13 1999-05-10 Тайхо Фармасьютикал Ко., Лтд. 3'-замещенные производные нуклеозида, способ их получения (варианты), лекарственное средство, способ лечения и профилактики
CA2172471C (en) * 1995-03-29 1999-01-26 Hua Qi Apparatus for and method of simulating ocular optical system
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
NZ547204A (en) 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
EP1435974A4 (en) 2001-09-28 2006-09-06 Idenix Cayman Ltd METHOD AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS WITH 4'-MODIFIED NUCLEOSIDES
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
NZ537662A (en) * 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
KR20050055630A (ko) * 2002-06-28 2005-06-13 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
JP2005533824A (ja) * 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウイルス科感染の治療のための２’−ｃ−メチル−３’−ｏ−ｌ−バリンエステルリボフラノシルシチジン
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
WO2004046331A2 (en) * 2002-11-15 2004-06-03 Idenix (Cayman) Limited 2’-branched nucleosides and flaviviridae mutation
WO2004052899A2 (en) * 2002-12-12 2004-06-24 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
BRPI0407374A (pt) * 2003-02-19 2006-01-10 Univ Yale Análogos de nucleosìdeo antiviral e métodos para tratar infecções virais, especialmente infecções de hiv
WO2006000922A2 (en) * 2004-06-23 2006-01-05 Idenix (Cayman) Limited 5-aza-7-deazapurine derivatives for treating infections with flaviviridae
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
KR101426101B1 (ko) * 2006-07-24 2014-08-13 다이호야쿠힌고교 가부시키가이샤 3＇-에티닐시티딘 유도체
JP5066737B2 (ja) 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
JP4954004B2 (ja) 2007-08-09 2012-06-13 株式会社バイオダイナミクス研究所 任意の化合物が導入された新規核酸誘導体、及びその製造方法
KR20100131457A (ko) 2008-03-27 2010-12-15 다이호야쿠힌고교 가부시키가이샤 시티딘 유도체 및 카르보플라틴을 함유하는 항종양제
US9556216B2 (en) 2012-08-31 2017-01-31 Novartis Ag 2′-Ethynyl nucleoside derivatives for treatment of viral infections
WO2018119284A1 (en) * 2016-12-22 2018-06-28 Calithera Biosciences, Inc. Ectonucleotidase inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480613A (en) * 1967-07-03 1969-11-25 Merck & Co Inc 2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
BE739821A (no) * 1968-10-04 1970-03-16
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
DE4204032A1 (de) * 1992-02-12 1993-08-19 Boehringer Mannheim Gmbh Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
EP0598910A1 (en) * 1992-03-11 1994-06-01 Japan Tobacco Inc. Process for producing nucleoside derivative
DE4418690A1 (de) * 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
RU2130029C1 (ru) * 1994-12-13 1999-05-10 Тайхо Фармасьютикал Ко., Лтд. 3'-замещенные производные нуклеозида, способ их получения (варианты), лекарственное средство, способ лечения и профилактики

Also Published As

Publication number Publication date
AU674639B2 (en) 1997-01-02
HUT75227A (en) 1997-04-28
US5763418A (en) 1998-06-09
CN1195768C (zh) 2005-04-06
NO305702B1 (no) 1999-07-12
HU9602214D0 (en) 1996-11-28
RU2130029C1 (ru) 1999-05-10
NO963350L (no) 1996-10-11
NZ297100A (en) 1997-10-24
USRE38090E1 (en) 2003-04-22
FI963148A (fi) 1996-08-12
HU217772B (hu) 2000-04-28
JP3142874B2 (ja) 2001-03-07
KR0177372B1 (ko) 1999-04-01
CA2182707C (en) 2000-05-30
CN1140453A (zh) 1997-01-15
PT747389E (pt) 2003-12-31
AU4188496A (en) 1996-07-03
KR970701198A (ko) 1997-03-17
FI963148A0 (fi) 1996-08-12
EP0747389A1 (en) 1996-12-11
DE69531729D1 (de) 2003-10-16
ATE249471T1 (de) 2003-09-15
DE69531729T2 (de) 2004-08-05
DK0747389T3 (da) 2004-01-26
EP0747389A4 (en) 1998-12-30
EP0747389B1 (en) 2003-09-10
ES2206522T3 (es) 2004-05-16
WO1996018636A1 (fr) 1996-06-20
FI118967B (fi) 2008-05-30

Similar Documents

Publication Publication Date Title
NO963350D0 (no) "3'-substituert nukleosid-derivat
DK0536936T3 (da) Pyrimidinnukleosidderivater med anti-tumor-aktivitet, deres fremstilling og anvendelse
ES2118069T3 (es) Profarmacos de fosfonatos.
DK535789A (da) Pyrimidindionderivater, fremgangsmaade til fremstilling heraf og antiarytmika omfattende samme
PL351500A1 (en) Use of cytidine derivatives for the treatment of leukaemia
DE69814375D1 (de) Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate
NL300247I1 (nl) 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten.
DE69025529D1 (de) Weitere antivirale Pyrimidin-Nukleosiden
CA2117883A1 (en) Erythromycin derivatives
ES2074719T3 (es) Derivados de nucleosido de pirimidina.
YU47802A (sh) Postupci i kompozicije za levovirin
ATE252590T1 (de) Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon
ATE72443T1 (de) Glucopyranose-derivate.
DE68901443D1 (de) Derivate von nukleosiden.
ES2164013A1 (es) Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
ES2067395A1 (es) Derivados de nucleosidos o analogos a nucleosidos.

Legal Events

Date Code Title Description
MK1K Patent expired